Gene · 6708
Papers1,813
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,421 to 1,440 of 1,813
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Initial characterization of the human central proteome. | BMC Syst Biol | 2011 | 21269460 | Swiss-Prot, curated | PubMed |
| Differential endothelial cell gene expression by African Americans versus Caucasian Americans: a possible contribution to health disparity in vascular disease and cancer. | BMC Med | 2011 | 21223544 | PubTator, text mining | PubMed |
| Synthesis and biological evaluation of a new series of 1,2,4-triazolo[1,5-a]-1,3,5-triazines as human A(2A) adenosine receptor antagonists with improved water solubility. | J Med Chem | 2011 | 21214204 | PubTator, text mining | PubMed |
| A genomic deletion causes truncation of α-spectrin and ellipto-poikilocytosis. | Blood Cells Mol Dis | 2011 | 21212007 | PubTator, text mining | PubMed |
| Molecular probes for the A2A adenosine receptor based on a pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine scaffold. | Bioorg Med Chem Lett | 2011 | 21185184 | PubTator, text mining | PubMed |
| Genomic safe harbors permit high β-globin transgene expression in thalassemia induced pluripotent stem cells. | Nat Biotechnol | 2011 | 21151124 | PubTator, text mining | PubMed |
| Expression profiles of podocytes exposed to high glucose reveal new insights into early diabetic glomerulopathy. | Lab Invest | 2011 | 21102505 | PubTator, text mining | PubMed |
| Highly efficient purification of protein complexes from mammalian cells using a novel streptavidin-binding peptide and hexahistidine tandem tag system: application to Bruton's tyrosine kinase. | Protein Sci | 2011 | 21080425 | PubTator, text mining | PubMed |
| On the association of lipid rafts to the spectrin skeleton in human erythrocytes. | Biochim Biophys Acta | 2011 | 20807499 | PubTator, text mining | PubMed |
| Structure based prediction of subtype-selectivity for adenosine receptor antagonists. | Neuropharmacology | 2011 | 20637786 | PubTator, text mining | PubMed |
| Specificity of interaction between clostridium perfringens enterotoxin and claudin-family tight junction proteins. | Toxins (Basel) | 2010 | 22069652 | PubTator, text mining | PubMed |
| Modeling G Protein-Coupled Receptors: a Concrete Possibility. | Chim Oggi | 2010 | 21253444 | PubTator, text mining | PubMed |
| American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations. | Endocr Pract | 2010 | 21216723 | PubTator, text mining | PubMed |
| Shape and Biomechanical Characteristics of Human Red Blood Cells in Health and Disease. | MRS Bull | 2010 | 21151848 | PubTator, text mining | PubMed |
| Highly conserved tyrosine stabilizes the active state of rhodopsin. | Proc Natl Acad Sci U S A | 2010 | 21041664 | PubTator, text mining | PubMed |
| hCB2 ligand-interaction landscape: cysteine residues critical to biarylpyrazole antagonist binding motif and receptor modulation. | Chem Biol | 2010 | 21035736 | PubTator, text mining | PubMed |
| Subtype selectivity of dopamine receptor ligands: insights from structure and ligand-based methods. | J Chem Inf Model | 2010 | 20936866 | PubTator, text mining | PubMed |
| Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. | Diabetes | 2010 | 20858683 | PubTator, text mining | PubMed |
| Beyond lamins other structural components of the nucleoskeleton. | Methods Cell Biol | 2010 | 20816232 | PubTator, text mining | PubMed |
| Synthesis and evaluation of 1,2,4-triazolo[1,5-c]pyrimidine derivatives as A2A receptor-selective antagonists. | Bioorg Med Chem Lett | 2010 | 20801028 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6708/papers?page=72